Alemtuzumab Compared With Chlorambucil As First-Line Therapy for Chronic Lymphocytic LeukemiaPeter Hillmen, Jiřı́ Mayer, Branimir Jakšić et al.|Journal of Clinical Oncology|2007Cited by 556
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical TrialRobin K. Avery, Sophie Alain, Barbara D. Alexander et al.|Clinical Infectious Diseases|2021Cited by 299